The approach to the management of the patient with neuropathic pain

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 11, 2010, Pages 4802-4811

  Vinik, Aaron ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN; CAPSAICIN; CITALOPRAM; DESIPRAMINE; DULOXETINE; ERGOCALCIFEROL; GABAPENTIN; GLUCOSE; HEMOGLOBIN A1C; IBUPROFEN; IMIPRAMINE; IMMUNOGLOBULIN; INSULIN ASPART; INSULIN GLARGINE; LAMOTRIGINE; LIDOCAINE; LORAZEPAM; NEUROTRANSMITTER; NORTRIPTYLINE; OXCARBAZEPINE; OXYCODONE; PAROXETINE; PREGABALIN; TOPIRAMATE; TRAMADOL; ZOLPIDEM TARTRATE;

AFFERENT NERVE GROUP 1; ANOREXIA; ANXIETY; ANXIETY DISORDER; APPLICATION SITE IRRITATION; ATAXIA; AUTOIMMUNE DISEASE; BLURRED VISION; BODY MASS; BODY WEIGHT; BRAIN CORTEX; BRAIN STEM; BULIMIA; CIGARETTE SMOKING; CLAUDICATION; CLAUSTROPHOBIA; CONFUSION; CONSTIPATION; DEPRESSION; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DYNAMOMETRY; DYSLIPIDEMIA; EDEMA; EYE EXAMINATION; FASCIITIS; FIBROMYALGIA; GLUCOSE BLOOD LEVEL; GRAND MAL SEIZURE; HASHIMOTO DISEASE; HEART ATRIUM ENLARGEMENT; HEART INFARCTION; HEMOGLOBIN DETERMINATION; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; IMPOTENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERMITTENT CLAUDICATION; LEUKOPENIA; LUNG CANCER; MONOTHERAPY; NAUSEA; NERVE COMPRESSION; NERVE FIBER C; NERVE INJURY; NEUROPATHIC PAIN; NITROSATIVE STRESS; NOCICEPTION; OXIDATIVE STRESS; PATHOGENESIS; PILATES; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SINUS TACHYCARDIA; SMOKING CESSATION; SOMNOLENCE; SPINAL CORD; SWEATING; TACHYCARDIA; TREMOR; URINE RETENTION; VASCULAR DISEASE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT CONTROL; WEIGHT GAIN; XEROSTOMIA; YOGA;

EID: 78049504483     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0892     Document Type: Review

References (55)

1. Mäntyselkä P, Ahonen R, Kumpusalo E, Takala J 2001 Variability in prescribing for musculoskeletal pain in Finnish primary health care. Pharm World Sci 23:232-236 (Pubitemid 34052639)
2. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J 2008 Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630-1635
3. Jensen MP, Chodroff MJ, Dworkin RH 2007 The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 68:1178-1182
4. Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C 2008 Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380-387
5. Vinik AI, Tuchman M, Safirstein B, Corder C, Kirby L, Wilks K, Quessy S, Blum D, Grainger J, White J, Silver M 2007 Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 128:169-179
6. Vinik A, Ullal J, Parson HK, Casellini CM 2006 Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab 2:269-281
7. Casellini CM, Vinik AI 2007 Clinical manifestations and current treatment options for diabetic neuropathies. Endocr Pract 13:550-566
8. Pittenger GL, Liu D, Vinik AI 1993 The toxic effects of serum from patients with type I diabetes mellitus on mouse neuroblastoma cells: a new mechanism for development of autonomic neuropathy. Diabetic Med 10:925-932
9. Torrance N, Smith BH, Bennett MI, Lee AJ 2006 The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7:281-289
10. Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC 2008 Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 137:681-688
11. Cornblath DR, Vinik A, Feldman E, Freeman R, Boulton AJ 2007 Surgical decompression for diabetic sensorimotor polyneuropathy. Diabetes Care 30:421-422
12. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton JR 2006 Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29:1294-1299
13. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A 2008 Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:464-469
14. Ziegler D, Rathmann W, Meisinger C, Dickhaus T, Mielck A 2009 Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry. Eur J Pain 13:582-587
15. Pittenger GL, Mehrabyan A, Simmons K, Rice A, Dublin C, Barlow P, Vinik AI 2005 Small fiber neuropathy is associated with the metabolic syndrome. Metab Syndr Relat Disord 3:113-121
16. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH 2005 Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341-350
17. Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, Vinik AI 2005 The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 7:497-508
18. Vinik AI, Strotmeyer ES, Nakave AA, Patel CV 2008 Diabetic neuropathy in older adults. Clin Geriatr Med 24:407-435, v
19. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, Broglio L, Granieri E, Lauria G 2008 The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131:1912-1925
20. Sorensen L, Molyneaux L, Yue DK 2006 The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 29:883-887
21. Kennedy WR 2004 Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve 29:756-767
22. Said G, Bigo A, Amëri A, Gayno JP, Elgrably F, Chanson P, Slama G 1998 Uncommon early-onset neuropathy in diabetic patients. J Neurol 245:61-68
23. Dogrul A, Uzbay IT 2004 Topical clonidine antinociception. Pain 111:385-391
24. Rains C, Bryson HM 1995 Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7:317-328
25. Derry S, Lloyd R, Moore RA, McQuay HJ 2009 Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 4:CD007393
26. Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M 2009 Efficacy and safety of combination therapy with5%lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 25:1677-1687
27. Jarvis B, Coukell AJ 1998 Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs 56:691-707
28. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M 1998 Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50:1842-1846
29. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, Donofrio P, Cornblath D, Olson WH, Kamin M 2000 Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 14:65-70
30. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB 1997 High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 48:1212-1218
31. Sang CN 2000 NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials. J Pain Symptom Manage 19:S21-S25
32. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH 2005 Algorithm for neuropathic pain treatment: an evidence-based proposal. Pain 118:289-305 (Pubitemid 41752987)
33. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R 1992 Effects of desipramine, amitryptiline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256
34. Kajdasz DK, Iyengar S, Desaiah D, Backonja MM, Farrar JT, Fishbain DA, Jensen TS, Rowbotham MC, Sang CN, Ziegler D, McQuay HJ 2007 Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther 29 Suppl:2536-2546
35. Sultan A, Gaskell H, Derry S, Moore RA 2008 Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol 8:29
36. Sansone RA, Sansone LA 2008 Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgmont) 5:16-19
37. Simpson DA 2001 Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 3:53-62 (Pubitemid 33130299)
38. Blom S 1962 Trigeminal neuralgia: its treatment with a new anticonvulsant drug (g-32883). Lancet 1:839-840
39. LaRoche SM, Helmers SL 2004 The new antiepileptic drugs: scientific review. JAMA 291:605-614
40. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A 2001 Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 57:505-509
41. Leach MJ, Marden CM, Miller AA 1986 Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490-497
42. Coderre TJ, Melzack R 1992 The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665-3670
43. Backonja MM 2002 Use of anticonvulsants for treatment of neuropathic pain. Neurology 59:S14-S17
44. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM 2003 Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60:1524-1534
45. Kalso E 2005 Sodium channel blockers in neuropathic pain. Curr Pharm Des 11:3005-3011
46. Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y 2005 Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 9:543-554
47. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E 1998 Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280:1831-1836
48. DeToledo JC, Toledo C, DeCerce J, Ramsay RE 1997 Changes in body weight with chronic, high-dose gabapentin therapy. Ther Drug Monit 19:394-396
49. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL 2005 Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352:1324-1334
50. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U 2004 Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110:628-638
51. Vinik AI 2008 Diabetic neuropathies: endpoints in clinical research studies. In: LeRoith D, Vinik AI, eds. Contemporary endocrinology: controversies in treating diabetes. Clinical and research aspects. Totowa, NJ: Humana Press; 135-156
52. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI 2004 To piramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63:865-873 (Pubitemid 39297649)
53. Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD 2005 An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 65:1306-1308
54. Tsai CP, Liu CY, Lin KP, Wang KC 2006 Efficacy of botulinum toxin type A in the relief of carpal tunnel syndrome: a preliminary experience. Clin Drug Investig 26:511-515
55. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G 1997 Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20:369-373